Originally Posted by Anonymous
It was a good meeting. Better than we had before. I personally believe Teva is a better, brighter organization than Cephalon and is focused on the future. But to think that Matt was the reason for change cannot be further from the truth. His inexperience and lack of confidence is still evident. I think Mark is solid with experience and the future of Oncology, not Matt.
Are you freakin kidding? Mark can hardly spell oncology. He is a clone of Matt, a pure cheerleader for upper management and a friend of Larry. The lack of territory sales quotas and this senior leadership is a recipe for failure.